These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17294113)

  • 1. High accuracy of virtual simulation with the laser system Dorado CT4.
    Rades D; Frenzel T; Schwarz R; Walz J; Cremers F; Albers D; Alberti W; Schmidt R
    Strahlenther Onkol; 2007 Feb; 183(2):89-93. PubMed ID: 17294113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulator verification of the accuracy of patient repositioning after virtual simulation. Is physical simulation still needed?
    Schüller P; Bruns F; Hesselmann S; Horn K; Panke JE; Schuck A; Schäfer U; Micke O; Willich N
    Strahlenther Onkol; 2002 Dec; 178(12):715-21. PubMed ID: 12491060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan.
    Chen YC; Chuang CK; Hsieh ML; Chen WC; Fan KH; Yeh CY; Lee CC; Hong JH
    Urology; 2007 Jul; 70(1):101-5. PubMed ID: 17656217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
    Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
    Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
    Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
    Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
    Rades D; Schwarz R; Todorovic M; Thurmann H; Graefen M; Walz J; Schild SE; Dunst J; Alberti W
    Strahlenther Onkol; 2007 Jul; 183(7):398-402. PubMed ID: 17609874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional versus virtual simulation for radiation treatment planning of prostate cancer: final results.
    Kantzou I; Platoni K; Sandilos P; Gouliamos A; Kouvaris I; Sarris G; Kelekis N; Kouloulias V
    J BUON; 2011; 16(2):309-15. PubMed ID: 21766503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
    Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Nd:YAG laser resection on symptom control, time to progression and survival in lung cancer patients.
    Zaric B; Canak V; Milovancev A; Jovanovic S; Budisin E; Sarcev T; Nisevic V
    J BUON; 2007; 12(3):361-8. PubMed ID: 17918290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
    Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
    Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
    Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
    Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
    Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer.
    Sato M; Mori T; Shirai S; Kishi K; Inagaki T; Hara I
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1002-9. PubMed ID: 18448272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.